PDS Biotechnology Corporation

Historical 13F Holders

Symbol
PDSB
CUSIP
70465T107
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 70465T107 since 12/18/2024, largest first.

Filer % of Class Filed
Nant Capital, LLC 13D
19.9% 9/21/2026
Event 9/14/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Armistice Capital, LLC 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 25 1.48 M $1.10M
2026 Q2 53 7.69 M $6.78M
2026 Q1 43 5.05 M $3.05M
2025 Q4 44 7.88 M $6.07M
2025 Q3 48 5.62 M $6.64M
2025 Q2 56 7.46 M $9.91M
2025 Q1 52 8.24 M $9.81M
2024 Q4 55 4.25 M $6.94M
2024 Q3 60 4.34 M $16.6M
2024 Q2 79 5.58 M $16.3M
2024 Q1 73 7.78 M $30.8M
2023 Q4 78 8.47 M $42.1M
2023 Q3 79 7.86 M $39.7M
2023 Q2 81 7.93 M $39.9M
2023 Q1 70 7.68 M $49.8M
2022 Q4 67 6.92 M $91.3M
2022 Q3 49 5.18 M $15.4M
2022 Q2 54 5.30 M $19.4M
2022 Q1 54 5.85 M $36.2M
2021 Q4 66 6.21 M $50.3M
2021 Q3 60 6.75 M $101M
2021 Q2 47 6.06 M $82.4M
2021 Q1 33 3.15 M $14.3M
2020 Q4 31 3.15 M $6.92M
2020 Q3 32 3.30 M $7.68M
2020 Q2 26 1.70 M $3.42M
2020 Q1 29 1.64 M $1.19M
2019 Q4 22 559 k $1.48M
2019 Q3 22 509 k $1.72M
2019 Q2 22 461 k $2.76M
2019 Q1 19 287 k $2.12M